Microglia display modest phagocytic capacity for extracellular tau oligomers

Abstract

BackgroundAbnormal misfolded tau protein is a driving force of neurofibrillary degeneration in Alzheimer’s disease. It has been shown that tau oligomers play a crucial role in the formation of intracellular neurofibrillary tangles. They are intermediates between soluble tau monomers and insoluble tau filaments and are suspected contributors to disease pathogenesis. Oligomeric tau can be released into the extracellular space and spread throughout the brain. This finding opens the question of whether brain macrophages or blood monocytes have the potential to phagocytose extracellular oligomeric tau.MethodsWe have used stable rat primary microglial cells, rat peripheral monocytes-derived macrophages, BV2 microglial and TIB67 macrophage immortalized cell lines that were challenged by tau oligomers prepared by an in vitro aggregation reaction. The efficiency of cells to phagocytose oligomeric protein was evaluated with confocal microscopy. The ability to degrade tau protein was analyzed by immunoblotting.ResultsConfocal microscopy analyses showed that macrophages were significantly more efficient in phagocytosing oligomerized tau proteins than microglial cells. In contrast to macrophages, microglia are able to degrade the internalized oligomeric tau only after stimulation with lipopolysaccharide (LPS).ConclusionsOur data suggests that microglia may not be the principal phagocytic cells able to target extracellular oligomeric tau. We found that peripheral macrophages display a high potency for elimination of oligomeric tau and therefore could play an important role in the modulation of neurofibrillary pathology in Alzheimer’s disease.Electronic supplementary materialThe online version of this article (doi:10.1186/s12974-014-0161-z) contains supplementary material, which is available to authorized users.

Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization

“…Our results indicate that LPS increases N9 microglia phagocytosis, as previously described for LPS-treated BV2 cells, as well as primary cultures of microglia and macrophages [73]. In vivo studies showed that LPS administration increases microglia phagocytosis of viable neurons during development, inflammation, and neuropathology, a property denominated as phagoptosis [74].…”

Distinct Therapeutic Mechanisms of Tau Antibodies

“…A recent study reported that microglia display modest levels of phagocytic capacity for Tau oligomers that are increased by LPS activation (10). It is not clear how microglia might clear antibody-bound Tau.…”

Systems-level analysis of peripheral blood gene expression in dementia patients reveals an innate immune response shared across multiple disorders

“…The most likely reason for the correlation observed between transcriptional changes in innate immune cells in blood and microglia in the CNS is that the inflammatory signals responsible for activating the microglial response are also present in blood. Inflammatory peptides are increased in the serum of AD patients [9], and there is evidence that monocytes are responsible for clearing circulating amyloid beta [35], tau [36], alpha-synuclein [37], and TDP-43 [38]. We saw no clear evidence of enrichment of neuron-, astrocyte-or oligodendrocyte-specific genes in any of the co-expression modules we identified in blood, which is unsurprising given that these other CNS cell types do not have analogous cell types in blood.…”